London-Sana
The director of the Oxford Vaccine Group, Andrew Pollard, said it was likely that a vaccine against the Omicron could be developed very quickly.
Agence France-Presse quoted Pollard, who led research on the Oxford AstraZeneca vaccine against the Corona virus, as saying that the spread of the new mutant severely among those vaccinated is highly unlikely, adding that in the event of the spread of Omicron, it will be possible to move very quickly because the paths to developing a new vaccine are steadily improving.
Pollard indicated that the current vaccines are effective against the Omicron mutant and will be confirmed in the coming weeks.
So far, no infections with the Omicron mutant have been detected in Britain, which is considered one of the most affected countries from Corona in Europe, but the government has imposed strict restrictions on travel to and from six African countries, where the mutant was first detected.